Molecular Development News Today

In the wake of that, messy disturbance that brought all of that rain and thunderstorms yesterday. See you later, storm system, it is long gone at this point. We will clear out. Fortynine is current temperature at airport. Chill in the air certainly but that is still in the bad, it is about 10 plus degree milder then we would be bottoming out on at this day of the year but d to upper 40s. More northwesterly wind flow. Note that is wind direction on the arrow there, that is going to be more of the...

All right, lets get started. Let me remind you to turn off the sound on your cell phones. This is our number 3263, denial in the face of fact. I asked for a science panel, i got an antiscience panel. [laughter] tom so im tom blumen thatll. Im the former chair of molecular and Development Biology here in boulder. I am the director of the institute for Downs Syndrome at the medical school. Let me briefly introduce the subject. I want you to imagine a world where they were accepted. Where nobody wa...

/PRNewswire/ -- Calico Life Sciences LLC (Calico), a biotechnology organization focused on the biology of aging and age-related diseases, and founded by...

The FDA has approved Veopoz (pozelimab-bbfg) for the treatment of CD55-deficient protein-losing enteropathy, also known as CHAPLE disease.

CHAPLE is an ultra-rare hereditary disease that can cause potentially life-threatening gastrointestinal and cardiovascular symptoms Approval represents 10th FDA-approved medicine invented by...

The FDA approval of pozelimab (Veopoz) makes it the first and only treatment indicated for children and adults with CHAPLE disease.